Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin and protein metabolism in critically ill septic children
NL-OMON29492Not yet recruiting
- Sponsor
- Erasmus MC Sophia Children's Hospital
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of human insulin and Travesol in sepsis, sponsored by Erasmus MC Sophia Children's Hospital. Primary endpoint: Whole-body protein balance. Planned start Nov 2009; status: not yet recruiting.
02
Drugs
human insulinTravesol
03
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON29492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29492.